Naloxegol oxalate bulk supplier for pharma manufacturers

Naloxegol Oxalate 12.5 mg, 25 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 12.5 mg, 25 mg

Reference Brands: Movantik (USA), Moventig (EU)

Naloxegol oxalate is a peripherally acting μ‑opioid receptor antagonist used to treat opioid‑induced constipation in adults with chronic non‑cancer pain who have not responded adequately to laxatives. It is a PEGylated derivative of naloxone designed to act mainly in the gastrointestinal tract without affecting central pain relief. Naloxegol is taken orally once daily, usually on an empty stomach. Available in 12.5 mg and 25 mg tablets, it helps improve bowel movement frequency. Common side effects include abdominal pain, diarrhea, nausea, flatulence, and headache.

Get Enquiry / Request Bulk Quote

Usually answered within 48 hours | GMP documents shared before you commit

Manufacture or export Naloxegol Oxalate? List it or send an offer →

Product Description:

Naloxegol oxalate is an orally active gastrointestinal drug belonging to the class of peripherally acting μ‑opioid receptor antagonists (PAMORAs), specifically designed to treat opioid‑induced constipation (OIC) in adult patients with chronic non‑cancer pain who have had an inadequate response to traditional laxatives. Because it is a PEGylated derivative of naloxone, naloxegol has significantly reduced ability to cross the blood‑brain barrier, so it preferentially blocks opioid receptors in the gastrointestinal tract without interfering with the central analgesic effects of opioids. This selectivity helps restore normal bowel function by counteracting the opioid‑induced slowing of gastrointestinal motility while maintaining pain control. Naloxegol is available in tablets of 12.5 mg and 25 mg, taken once daily on an empty stomach. In the United States, it is marketed under the brand Movantik, and in the European Union and United Kingdom, it is marketed as Moventig. The dosing may be adjusted for patients with renal impairment, and treatment should be discontinued if opioid therapy is stopped. Common side effects include abdominal pain, diarrhea, nausea, flatulence, vomiting, and headache, generally mild to moderate in severity.

Naloxegol Oxalate — third party manufacturing & bulk supply

Naloxegol Oxalate 12.5 mg, 25 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Naloxegol Oxalate is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Naloxegol Oxalate listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Naloxegol Oxalate →

Usually answered within 48 hours, with matched manufacturers, indicative prices and document status.

Back to Listing

Frequently Asked Questions

Naloxegol oxalate is used to treat

Naloxegol is a PEGylated derivative of naloxone, formulated as

The main trade names for naloxegol are

Naloxegol products such as Movantik and Moventig are manufactured and marketed by companies licensed in respective regions for opioid‑induced constipation treatment.

The generic name of Movantik is

Brand names for naloxegol include

Naloxegol oxalate tablets are manufactured under regulated pharmaceutical conditions by the respective brand marketing companies and their licensed manufacturers for regional distribution.